Komboglyze Articles
IQWiG re-assessments come up with same view for saxagliptin and different for crizotinib
14 May 2013
EC approves additional use for Bristol-Myers and AstraZeneca’s Onglyza and Komboglyze
29 November 2011
Approval of diabetes drugs from AstraZeneca/B-MS and Novo Nordisk supported by EU’s CHMP; Faslodex cleared in Japan
26 September 2011
Showing 1-4 of 4 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
